CryoPort (NASDAQ:CYRX) Director Ramkumar Mandalam Sells 23,214 Shares

CryoPort, Inc. (NASDAQ:CYRX) Director Ramkumar Mandalam sold 23,214 shares of CryoPort stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $15.44, for a total transaction of $358,424.16. Following the completion of the sale, the director owned 67,894 shares of the company’s stock, valued at $1,048,283.36. This represents a 25.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

CryoPort Stock Down 1.4%

Shares of CYRX stock opened at $15.48 on Tuesday. The company has a 50 day moving average price of $11.89 and a 200-day moving average price of $10.17. CryoPort, Inc. has a 52 week low of $6.16 and a 52 week high of $16.73. The firm has a market capitalization of $780.19 million, a PE ratio of 11.47 and a beta of 1.90.

CryoPort (NASDAQ:CYRX) last announced its quarterly earnings results on Monday, May 4th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.03). The company had revenue of $47.80 million during the quarter, compared to the consensus estimate of $44.86 million. CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%. Analysts anticipate that CryoPort, Inc. will post -0.85 earnings per share for the current year.

Hedge Funds Weigh In On CryoPort

Hedge funds have recently modified their holdings of the company. UBS Group AG lifted its holdings in shares of CryoPort by 6.8% in the fourth quarter. UBS Group AG now owns 1,421,884 shares of the company’s stock worth $13,650,000 after buying an additional 90,363 shares in the last quarter. Mak Capital One LLC purchased a new position in shares of CryoPort in the third quarter worth $7,756,000. First Eagle Investment Management LLC purchased a new position in shares of CryoPort in the fourth quarter worth $2,996,000. Legato Capital Management LLC purchased a new position in shares of CryoPort in the fourth quarter worth $443,000. Finally, Segall Bryant & Hamill LLC purchased a new position in shares of CryoPort in the third quarter worth $652,000. 92.90% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. BTIG Research raised their price objective on shares of CryoPort from $15.00 to $17.00 and gave the stock a “buy” rating in a report on Tuesday, May 5th. Weiss Ratings raised shares of CryoPort from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th. KeyCorp raised their price objective on shares of CryoPort from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Craig Hallum raised their price objective on shares of CryoPort from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Finally, Needham & Company LLC raised their price objective on shares of CryoPort from $13.00 to $15.00 and gave the stock a “buy” rating in a report on Tuesday, May 5th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, CryoPort presently has a consensus rating of “Moderate Buy” and a consensus target price of $15.11.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.